SHERPA initiates studies to validate AI-based technologies for minimally invasive brain and cancer treatments
The Philips-coordinated SHERPA research consortium has initiated seven clinical studies to demonstrate the benefits of AI and robotics-assisted workflows in minimally invasive treatments for brain aneurysms and liver tumours. Staff shortages, coupled with the complex nature of the work, place significant pressure on interventional radiologists and interventional neuroradiologists. The SHERPA consortium aims to validate AI-powered […]
Read More










